Search results
Kiora Pharmaceuticals director buys $25,668 in company stock By Investing.com
Investing.com· 9 hours agoOn June 13, 2024, Parsons acquired 5,260 shares of common stock at a price of $4.88 per share. This...
Insider Sale: SVP, Chief Technology Officer Silji Abraham Sells Shares of West Pharmaceutical ... By...
Investing.com· 12 hours agoThe transaction was reported in a recent SEC Filing. Following this transaction, the insider now...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 3 hours agoBUSINESS In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly was on...
Pacira BioSciences COO sells shares worth $28,380 By Investing.com
Investing.com· 7 hours agoPacira BioSciences, Inc. (NASDAQ:PCRX), a pharmaceutical company specializing in non-opioid pain...
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 6 hours agoOn June 12, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex ...
Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Up 1.8%
ETF DAILY NEWS· 21 hours agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) rose 1.8% on Tuesday . The company traded as high as $259.45 and last traded at $259.45.
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 7 days agocompany has been reinvesting all of its profits into the business. This is likely what's driving the...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 14 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives New Coverage from Analysts at Rodman & Renshaw
ETF DAILY NEWS· 1 day agoThe brokerage issued a buy rating and a $27.00 target price on the stock. Needham & Company LLC reaffirmed a buy rating and issued a $22.00 price objective on shares of Avadel ...
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
Reuters via AOL· 7 hours agoTeva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on...